The vaccine that the French group Sanofi is developing against covid-19 for release in June 2021 will not need to be stored in the freezer, Sanofi France president Olivier Bogillot said on CNews on Sunday. Unlike the vaccine developed by the American Pfizer and the German BioNTech, which is in the lead but requires very low temperatures (-70 ° C) to be stored, “our vaccine will be like the flu vaccine, you can put it in your fridge, “said Olivier Bogillot, on the CNews channel. “We will not have this pitfall, it will be an advantage for some countries”.
The vaccine could be distributed “from June 2021,” said Olivier Bogillot. The results of phase 2 trials “on several hundred patients” should be made public in early December and they are not “negative” for the moment, he said.
If these results prove to be positive, Sanofi will launch phase 3 trials “on several tens of thousands of patients” and take the “risk” of “simultaneously launching production”. The results of phase 3 should then be published in May. The laboratory does not yet know whether it will take “one or two doses” for the vaccine to be effective.
“The objective is to reach the end of 2021 with one billion doses. In 2022 we can even increase production to go beyond this figure,” said the president of Sanofi France.